H&K AG

  • WKN: A11Q13
  • ISIN: DE000A11Q133
  • Land: Deutschland

Nachricht vom 21.04.2017 | 11:05

H&K AG: Citi mandated


DGAP-Media / 21.04.2017 / 11:05

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT. 

H&K AG, being the ultimate parent company of the Heckler & Koch Group, has mandated Citi to arrange a series of fixed income investor meetings commencing on 27th April in London. A debt capital markets transaction may follow in the near future subject to management decision and market conditions. Relevant stabilisation regulations including FCA/ICMA will apply. 

These materials are for informational purposes only and are not intended to constitute, and should not be construed as, an offer to sell or subscribe for, or the announcement of a forthcoming offer to sell or subscribe for, or a solicitation of any offer to buy or subscribe for, or the announcement of a forthcoming solicitation of any offer to buy or subscribe for, any securities of H&K AG in any jurisdiction whatsoever.  

Securities of H&K AG have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States absent registration or an exemption from the registration requirements under the Securities Act. H&K AG does not intend to register any portion of any offering of securities in the United States or to conduct any public offering of securities in the United States.



End of Media Release


Issuer: H&K AG
Key word(s): Enterprise

21.04.2017 Dissemination of a Press Release, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

23. MKK – Münchner Kapitalmarkt Konferenz

Für: Institutionelle Investoren & Presse

Wann: 26. & 27. April 2017, 9 - 17 Uhr

Wo: The Charles Hotel - Rocco Forte Hotels, München

GBC im Fokus

Neovacs S.A.: Kursziel auf 3,30 € angehoben

In den letzten Monaten hatte die Neovacs S.A. einen positiven Newsflow. Im Vordergrund steht die Vertriebspartnerschaft für den chinesischen Markt, wodurch sich bis nach dem ersten Vermarktungsjahr Gesamterträge von bis zu 65 Mio. € ergeben können. Zudem verläuft der klinische Zulassungsprozess des IFNα-Kinoid zur Behandlung von SLE (Systemischer Lupus) und Dermatomyositis planmäßig. Wir haben in unsere Bewertung aktualisiert und ein Kursziel von 3,30 € je Aktie (bisher: 2,90 €) ermittelt. Das Rating lautet weiter KAUFEN.

News im Fokus

Continental startklar: Nächster Wachstumsschub durch innovative Antriebstechnologien

25. April 2017, 08:30

Aktueller Webcast

Scout24 AG

Q1 Results 2017

10. Mai 2017

Aktuelle Research-Studie

Ludwig Beck am Rathauseck-Textilhaus Feldmeier AG

Original-Research: Ludwig Beck AG (von Montega AG): Kaufen

25. April 2017